# Phase II Study of Docetaxel Plus CDDP for NSCLC Stage III

> **NCT00172380** · PHASE2 · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 41 (actual)

## Conditions studied

- NSCLC

## Interventions

- **DRUG:** Docetaxel Plus CDDP

## Key facts

- **NCT ID:** NCT00172380
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2010-01
- **Final completion:** 2010-03
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2012-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00172380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00172380, "Phase II Study of Docetaxel Plus CDDP for NSCLC Stage III". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT00172380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*